Further studies demonstrated that the combination of the inhibitor of NETs (DNase I) and recombinant tissue-type plasminogen activator (rt-PA) exerted a protective effect against myocardial ischemia-reperfusion (69). The gene discussed is PLAT; the disease is myocardial ischemia.